Monoclonal Anti-Monkeypox-A30L Antibody, Human IgG1 (8A2) (MALS & SPR verified)

Monkeypox is a rare zoonosis caused by monkeypox virus, which has become the most serious orthpoxvirus and consists of complex double stranded DNA. The pathogenesis of monkeypox is that the virus invades the body from respiratory mucosa , multiplies in lymphocytes, and incurs into blood producing transient venereal toxemia. after the virus multiplies in cells, the cells can invade the blood and propagate to the skin of the whole body, causing lesions. A30L is a Envelope protein required for virus entry into host cell and for cell-cell fusion (syncytium formation).

Product Specifications

Background

CAS Number

9007-83-4

Host

HEK 293

Origin Species

Human

Target

A30L (MPXV)

Conjugation

Unconjugated

Tag

Human IgG1 | Human Kappa

Stability

-20°C to -70°C for 12 months in lyophilized state; -70°C for 3 months under sterile conditions after reconstitution._x000D_For long term storage, the product should be stored at lyophilized state at -20°C or lower._x000D_Please avoid repeated freeze-thaw cycles.

Purity

90%

Bioactivity

Immobilized Monoclonal Anti-Monkeypox-A30L Antibody, Human IgG1 (8A2) (Cat. No. A3L-M572) at 1 μg/mL (100 μL/well) can bind Monkeypox virus (strain Zaire-96-I-16) A30L, His Tag (Cat. No. A3L-M5243) with a linear range of 0.5-16 ng/mL (QC tested).